ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NDRA ENDRA Life Sciences Inc

0.285
0.0039 (1.39%)
May 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 52,595
Bid Price 0.2822
Ask Price 0.29
News -
Day High 0.2987

Low
0.221

52 Week Range

High
2.77

Day Low 0.28
Company Name Stock Ticker Symbol Market Type
ENDRA Life Sciences Inc NDRA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0039 1.39% 0.285 18:08:26
Open Price Low Price High Price Close Price Prev Close
0.285 0.28 0.2987 0.2822 0.2811
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
190 52,595 $ 0.2821294 $ 14,839 - 0.221 - 2.77
Last Trade Time Type Quantity Stock Price Currency
18:05:40 1 $ 0.29 USD

ENDRA Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.37M 8.45M - 0 -10.06M -1.19 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ENDRA Life Sciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NDRA Message Board. Create One! See More Posts on NDRA Message Board See More Message Board Posts

Historical NDRA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.28220.3440.280.3064988192,6520.00280.99%
1 Month0.2520.3798990.24220.3049066121,7630.03313.10%
3 Months1.131.240.2210.6023392191,611-0.845-74.78%
6 Months0.9462.770.2210.9416493150,143-0.661-69.87%
1 Year1.562.770.2211.04115,994-1.28-81.73%
3 Years44.4048.800.2219.90432,952-44.12-99.36%
5 Years21.6062.000.22123.65519,422-21.32-98.68%

ENDRA Life Sciences Description

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Your Recent History

Delayed Upgrade Clock